FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics and medicine, and concerns a semi-solid composition and a semi-solid pharmaceutical product applicable in photodynamic therapy (PDT) of cancer, pre-cancer and non-cancer conditions of a female reproductive system, an anus and a penis, and contain an active ingredient which represent 5-aminolevulinic acid (5-ALA) ester or its pharmaceutically acceptable salts, one or more triglycerides, one or more viscosity enhancers specified in cellulose or its derivatives, synthetic polymers, polyethylene glycols, vegetable gums, starch and starch derivatives, carrageenan, agar, gelatine, wax and waxy solid substances. Further, the invention refers to a kit for photodynamic therapy.
EFFECT: group of inventions provides stability of the composition and product at room temperature, ease of use for a patient.
19 cl, 2 dwg, 10 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING 5-AMINOLEVULINIC ACID AND DERIVATIVES THEREOF IN SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSTICS | 2008 |
|
RU2521228C2 |
| SOLID COMPOSITIONS CONTAINING 5-AMINOLEVULINIC ACID | 2010 |
|
RU2527328C2 |
| IRRADIATOR | 2014 |
|
RU2705606C2 |
| EMITTER | 2009 |
|
RU2487740C2 |
| NANOEMULSION | 2007 |
|
RU2491917C2 |
| EMITTER | 2009 |
|
RU2619790C2 |
| NEO-ADJUVANT THERAPY FOR BLADDER CANCER | 2016 |
|
RU2783177C2 |
| INTRAVESICAL THERAPY FOR BLADDER CANCER | 2016 |
|
RU2779543C2 |
| HYDROPHILIC GEL FOR LOCAL DELIVERY OF 5-AMINOLEVULINIC ACID | 2016 |
|
RU2723339C2 |
| METHOD OF PHOTODYNAMIC THERAPY (PDT) OF BLADDER CANCER | 2016 |
|
RU2745194C2 |
